Výsledky vyhledávání - "Isabelle Bourdeix"

Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease

Autor: Thierry Perez, Pierre-Régis Burgel, Laurent Decuypère, Isabelle Bourdeix, Vincent Le Gros, Gaëtan Deslée

Publikováno v: BMC Pulmonary Medicine
BMC Pulmonary Medicine, BioMed Central, 2017, 17, pp.25. ⟨10.1186/s12890-017-0372-z⟩
BMC Pulmonary Medicine, 2017, 17, pp.25. ⟨10.1186/s12890-017-0372-z⟩

The purpose of this study was to evaluate the correlation between immediate responsiveness with the short-acting β2-agonist salbutamol and effects of treatment with the ultra-long-acting β2-agonist indacaterol in patients with chronic obstructive p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5edc716d929e8e6a47e1e445f2bb0a73
https://hal.univ-reims.fr/hal-02451056

Zobrazit plný text záznamu

Anxiety and Coping Strategy Changes in Multiple Sclerosis Patients Initiating Fingolimod: The GRACE Prospective Study

Autor: Florent Borgel, Thibault Moreau, Mohamed Meite, Catherine Bungener, Olivier Heinzlef, Karin Rerat, Isabelle Chouette, Laurent Suchet, Isabelle Bourdeix

Publikováno v: European neurology. 77(1-2)

The objective of this prospective study was to assess the changes in anxiety levels, and their relationship with coping strategies over the first four months of fingolimod treatment in patients with relapsing remitting multiple sclerosis (RRMS). Data

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7a473796263ee6dc7ec9dd309b61d96
https://pubmed.ncbi.nlm.nih.gov/27907914

Zobrazit plný text záznamu

SALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction

Autor: Guillemette, Laval, Hubert, Rousselot, Sophie, Toussaint-Martel, Françoise, Mayer, Eric, Terrebonne, Eric, François, Hédia, Brixi, Thierry, Nguyen, Isabelle, Bourdeix, Ségolène, Bisot-Locard, Laurent, Zelek, Karine, Moutel

Publikováno v: Bulletin du Cancer. 99:E1-E9

This phase II, multicenter, randomized, double-blind, non-comparative study assessed the efficacy and safety of immediate-release octreotide and octreotide LAR, in combination with corticosteroids and standard medical care, on the symptoms of inopera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e6d9ce7b29cf052632d50a6786b06f
https://doi.org/10.1684/bdc.2011.1535

Zobrazit plný text záznamu

Omalizumab-induced decrease of FcɛRI expression in patients with severe allergic asthma

Autor: Manuel Tunon de Lara, Cécile Contin-Bordes, Christophe Verkindre, Jean-François Moreau, Marc Humbert, Gilles Garcia, Alain Didier, Vincent Le Gros, Isabelle Bourdeix, Pascal Chanez, Patrick Trunet, Frédéric de Blay, Mathieu Molimard, Philip Robinson, Patrick Blanco

Publikováno v: Respiratory Medicine. 104(11):1608-1617

SummaryBackgroundIt is documented that omalizumab treatment reduces the cell surface expression of immunoglobulin E high-affinity receptor (FcɛRI) on several cell types. This has not been investigated in patients with uncontrolled severe persistent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83f5428b0622eac8e31c83ecee21cae0

Zobrazit plný text záznamu

Parkinson's disease dementia can be easily detected in routine clinical practice

Autor: Isabelle Bourdeix, Bruno Dubois, Jean-Jacques Pere, Alain Duhamel, François Tison, Franck Durif, Kathy Dujardin

Publikováno v: Movement Disorders. 25:2769-2776

Parkinson's disease (PD) is mainly characterized by its motor manifestations, but it is also frequently associated with dementia. Early diagnosis of PD dementia (PDD) is particularly important because effective cholinesterase inhibitor treatments are

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e445466b01751f20f21a9abe7e3cdc61
https://doi.org/10.1002/mds.23391

Zobrazit plný text záznamu

Insights into severe asthma control as assessed by guidelines, pulmonologist, patient, and partner

Autor: Vincent Le Gros, Isabelle Bourdeix, Mathieu Molimard, Anne Ponthieux, Daniel Vervloet

Publikováno v: Journal of Asthma. :1-7

The most recent guidelines on asthma management advocate a treatment strategy based on control of the disease rather than severity, a switch based on reported evidence.This observational, questionnaire-based study set out to investigate how control o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fb4706fccc22e5eccff1afcd1c59726
https://doi.org/10.1080/02770903.2010.491139

Zobrazit plný text záznamu

Is There a Difference between Levodopa/ Dopa-Decarboxylase Inhibitor and Entacapone and Levodopa/Dopa-Decarboxylase Inhibitor Dose Fractionation Strategies in Parkinson’s Disease Patients Experiencing Symptom Re-Emergence due to Wearing-Off?

Autor: Isabelle Bourdeix, Alain Destée, Karin Rerat

Publikováno v: European Neurology. 61:69-75

Two strategies to manage symptom re-emergence due to wearing-off with conventional levodopa/dopa-decarboxylase inhibitor (DDCI) therapy were compared in patients with Parkinson’s disease (PD) in this randomized, open-label trial. PD patients receiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9417ac6be51dd87a330ae5e6918ad1e
https://doi.org/10.1159/000177938

Zobrazit plný text záznamu

Levodopa/DDCI and entacapone is the preferred treatment for Parkinson’s disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort

Autor: Karin Rerat, M. Ziegler, Isabelle Bourdeix, F. Viallet, Philippe Damier

Publikováno v: European Journal of Neurology. 15:643-648

Levodopa is the gold standard drug for the symptomatic control of Parkinson's disease (PD). However, long-term treatment with conventional formulations [levodopa and a dopa decarboxylase inhibitor (DDCI)], is associated with re-emergence of symptoms

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::35d1dbfb5b1acb962a5230fa51b85c35
https://doi.org/10.1111/j.1468-1331.2008.02165.x

Zobrazit plný text záznamu

Impact of ELN recommendations in the management of first-line treated chronic myeloid leukaemia patients: a French cross-sectional study

Autor: Nathalie Carpentier, Franck E. Nicolini, Michel Tulliez, Charles Dauriac, Françoise Huguet, Gabriel Etienne, Pascale Cony-Makhoul, Isabelle Bourdeix, Valérie Coiteux, Agnès Guerci-Bresler, Frédéric Maloisel

Publikováno v: British journal of haematology. 174(1)

The availability of tyrosine kinase inhibitors has extended therapeutic options for chronic myeloid leukaemia (CML) patients. Monitoring recommendations and clinical response goals have recently been updated. The objective of this study was to descri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4539a5d07c7404e4964b8c78135ed981
https://pubmed.ncbi.nlm.nih.gov/27060881

Zobrazit plný text záznamu

Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD

Autor: Vincent Le Gros, Isabelle Bourdeix, Jacques Bourcereau, Mathieu Molimard

Publikováno v: Respiratory Medicine. 99:695-702

Summary Rationale : The Global Initiative for Chronic Obstructive Lung Disease guidelines recommend bronchodilator reversibility testing to guide treatment decisions. This study evaluated the relationship between the change in forced expiratory volum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a430100d25a32554471570b03a1dfaf
https://doi.org/10.1016/j.rmed.2004.11.009

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání